Telemedicine Microcart Packed Into a Self-Deployable Carry-on Bag Offers Practitioners Full Range of Customizable Telediagnostic Solutions to Deliver Patient Care Regardless of Location
Henry Schein Medical, the U.S. medical business of Henry Schein, Inc. (Nasdaq: HSIC) and the exclusive distributor of Medpod Inc. products and services, today announced enhancements to the first telemedicine microcart™ packed into a rapidly self-deployable carry-on bag, the Medpod® MobileDoc 2. Building on the success of the original MobileDoc, the new Medpod® MobileDoc 2 enables the mobilization of care to the patient location, expanding provider reach with remote consultations, and quickly transforms any environment into a clinical care setting, such as homes, offices, schools, ambulances, and senior care facilities.
“Together with Medpod, we look forward to expanding off-site point-of-care options our customers can rely on to meet their patients’ portable needs.”
Medpod® MobileDoc 2 leverages the latest advancements in live, cloud-based, two-way televideo communication and real-time streams of clinical data from medical devices, empowering remote providers with the ability to capture a wide range of clinical diagnostic and laboratory patient data to aid in decision making and improved patient outcomes.
“Henry Schein Medical is eager to bring this enhanced Medpod offering to our customers in multiple market segments, helping transform their practices and improve relationships with patients looking for convenient access to health care,” said Brad Connett, President, U.S. Medical Group, Henry Schein. “Together with Medpod, we look forward to expanding off-site point-of-care options our customers can rely on to meet their patients’ portable needs.”
Medpod’s cloud-based software and modular infrastructure gives providers and operators the ability to implement a solution that is tailored to their needs, while improving the quality of the clinical encounter. The new enhancements give practitioners a full suite of telediagnostic solutions to choose from, helping health care professionals deliver customizable, high-quality, and convenient care that meets the needs of patients who cannot visit a traditional office setting.
The patent-pending MobileDoc 2 features professional-grade medical devices and instruments — such as dermatoscopes (examines skin lesions) and electrocardiograms (detects heart attacks and heart rhythm problems) — with state-of-the-art HD video and EHR connectivity. With this new solution, health care professionals can transform any environment into a clinical care setting, including conducting basic exams, checking vitals, and performing specialty testing—breaking the boundaries of traditional care.
Additional enhancements to the MobileDoc 2 include new functionality that allows customers to give patients access to their providers via the web or dedicated app. The Medpod virtual care software requires little to no hardware or software installation, creates new revenue sources, offers a cost-effective solution with a pay-per-visit or prepaid fee model, and can be used for either post-acute inpatient or outpatient monitoring. When appropriate, and a diagnostic exam is deemed necessary, a MobileDoc 2 can be dispatched to provide clinically meaningful care. In addition to these enhancements, Medpod also features live translation services, which provides remote video translation in 250 languages with 24/7 on-demand access to maintain high-level, convenient patient care with visual communication.
“By transforming telemedicine with a comprehensive and scalable telediagnostics platform, Medpod connects software and medical devices, optimizes health care delivery, and maximizes patient management throughout the continuum of care,” said Jack Tawil, Chairman and Chief Executive Officer, Medpod Inc. “Thanks to our distributor partner, Henry Schein, we can help practitioners break down the barriers to deliver high quality, convenient care.”
For more information, call 1.800.P.SCHEIN or visit www.HenrySchein.com/Medpod.
About Henry Schein, Inc.
Henry Schein, Inc. (Nasdaq: HSIC) is a solutions company for health care professionals powered by a network of people and technology. With more than 19,000 Team Schein Members worldwide, the Company’s network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.
Henry Schein operates through a centralized and automated distribution network, with a selection of more than 120,000 branded products and Henry Schein private-brand products in stock, as well as more than 180,000 additional products available as special-order items.
A FORTUNE 500 Company and a member of the S&P 500® and the Nasdaq 100® indexes, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 31 countries. The Company’s sales from continuing operations reached $9.4 billion in 2018, and have grown at a compound annual rate of approximately 13 percent since Henry Schein became a public company in 1995.